FDA Releases New Guidelines on Scientific Literature Used for Promotional Purposes

The FDA has released a new checklist meant to clarify the ways a pharmaceutical manufacturer may use scientific and medical literature to promote products.  The checklist constitute a revision of 2009 guidelines that were criticized for restricting companies’ ability to “promote the public health.”  The new guidelines call for an emphasis on science, not promotion, and also recommends that literature not be funded – either in whole or in part – or distributed by a company.

FDA Guidelines →

Of further interest:
FDA Releases Guidance on Use of Scientific and Medical Literature for Promotional Purposes (Regulatory Focus)